Objective: Neurogenic bladder dysfunction due to spinal cord injury (SCI) poses a significant threat to the well-being of patients. The complications of this condition include but not are limited to incontinence, renal impairment, urinary tract infection, stones, and poor quality of life. Clinical manifestations of SCI involve combination of storage and voiding bladder problems. Although a number of clinical studies have reported overactive bladder (OAB) after SCI, the pathophysiological mechanisms remain unclear. SCI is widely used to induce neurogenic bladder in rodent models. These animals exhibited dysfunctional condition results in different symptoms, ranging from acute urinary retention to an OAB or a combination of both. 
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